Beyond Weight Bias: Lessons from a Patient’s Progression to Stage 4 MASH

For many clinicians, metabolic dysfunction-associated steatohepatitis (MASH) — formerly known as NASH — presents a diagnostic and management challenge. Dianne Gillard’s story, a U.K.-based patient advocate, highlights the real-world consequences of missed diagnostic opportunities and underscores the need for earlier detection, patient-centered communication, and system-wide changes in fatty liver disease screening.